Showing 1,308 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Injectable & long-acting HIV treatment

Long-acting injectables appear feasible for long-term HIV treatment

News
4 November 2020
The search for a cure

Could a multiple sclerosis medication be used against the HIV reservoir?

News
2 November 2020
New & experimental HIV treatments

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

News
29 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Injectable & long-acting HIV treatment

Long-acting injectables work without oral lead-in period

News
11 October 2020
New & experimental HIV treatments

Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes

Editor's pick
i-Base
9 October 2020
New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
New & experimental HIV treatments

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

Editor's pick
POZ
2 September 2020
Resistance

“Unprecedented” case of transmission of four-class resistant HIV virus reported in France

News
11 August 2020
Injectable & long-acting HIV treatment

Doravirine injections were safe and long-lasting, but did not reach therapeutic levels

News
4 August 2020
Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
New & experimental HIV treatments

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Editor's pick
TheBodyPro
28 July 2020
HIV treatment

Top 5 HIV treatment stories at AIDS 2020

News
28 July 2020
The search for a cure

Promising results for vesatolimod in monkeys and humans

News
14 July 2020
New & experimental HIV treatments

FDA spurns CytoDyn's HIV drug because of missing info

Editor's pick
FierceBiotech
14 July 2020
New & experimental HIV treatments

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

Editor's pick
Dewpoint press release
13 July 2020
Resistance

Doravirine Benefits HIV-1 Patients with Common Resistance Associated Mutations

Editor's pick
Contagion Live
8 July 2020
The search for a cure

Has someone been cured of HIV with a cheap, simple drug regimen?

News
7 July 2020
New & experimental HIV treatments

Islatravir plus doravirine maintains viral suppression for a year

News
5 July 2020
Injectable & long-acting HIV treatment

GSK says it is within weeks of resubmitting HIV injection Cabenuva

Editor's pick
Reuters
3 July 2020
New & experimental HIV treatments

ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available

Editor's pick
ViiV press release
3 July 2020